Post Abortion Women’s Perceptions of Utilizing Long Acting Reversible Contraceptive Methods in Uganda. A Qualitative Study


Background: About one-third of all pregnancies that occur in low income countries are unintended. An estimated 1.2 million unwanted pregnancies occur in Uganda annually. The majority of the unwanted pregnancies end in unsafe abortion which is one of the five direct causes of maternal mortality. Abortion related complications are responsible for 26% of all maternal deaths in Uganda. Abortion complications can be avoided if women appropriately use contraception to avoid unwanted pregnancy. However, in Uganda the contraceptive prevalence is low at 30% and less than 4% of women rely on long acting reversible contraceptives. Aim: We aimed to explore post-abortion women’s perceptions of using of long acting reversible contraception (LARC). Methods: A qualitative research design was used for data collection and analysis. Thirty in-depth interviews with post abortion women in Mulago hospital were carried out using an interview guide. Interviews were transcribed and coded using nodes and subsequently through query, we derived themes. Results: Emergent themes regarding women perceptions of using LARC methods were myths and misinformation, fear of side effects, women’s lived experiences, relatives’ influence, health providers’ perceptions, lack of knowledge and women desire for spacing children for a long time. Conclusion and recommendations: The majority of women were skeptical about using LARC. There is a need to educate women to dispel myths, misinformation and quality counseling to address the benefits and side effects of LARC. There is also a need to revamp the knowledge and skills of the healthcare providers regarding LARC methods.

Share and Cite:

Kakaire, O. , Nakiggude, J. , Lule, J. and Byamugisha, J. (2014) Post Abortion Women’s Perceptions of Utilizing Long Acting Reversible Contraceptive Methods in Uganda. A Qualitative Study. Open Journal of Obstetrics and Gynecology, 4, 1087-1097. doi: 10.4236/ojog.2014.416150.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Blumenthal, P.D., Voedisch, A. and Gemzell-Danielsson, K. (2011) Strategies to Prevent Unintended Pregnancy: Increasing Use of Long-Acting Reversible Contraception. Human Reproduction Update, 17, 121-137.
[2] World Health Organization (2012) Facts on Induced Abortion Worldwide. World Health Organization, Geneva.
[3] Hubacher, D., Mavranezouli, I. and McGinn, E. (2008) Unintended Pregnancy in Sub-Saharan Africa: Magnitude of the Problem and Potential Role of Contraceptive Implants to Alleviate It. Contraception, 78, 73-78.
[4] Jones, E.F. and Forrest, J.D. (1992) Contraceptive Failure Rates Based on the 1988 NSFG. Family Planning Perspectives, 24, 12-19.
[5] Finer, L.B. and Henshaw, S.K. (2006) Disparities in Rates of Unintended Pregnancy in the United States, 1994 and 2001. Perspectives on Sexual and Reproductive Health, 38, 90-96.
[6] Jones, R.K., Zolna, M.R., Henshaw, S.K. and Finer, L.B. (2008) Abortion in the United States: Incidence and Access to Services, 2005. Perspectives on Sexual and Reproductive Health, 40, 6-16.
[7] Jones, R.K., Darroch, J.E. and Henshaw, S.K. (2002) Contraceptive Use among US Women Having Abortions in 2000-2001. Perspectives on Sexual and Reproductive Health, 34, 294-303.
[8] Uganda Bureau of Statistics (UBOS) and ICF International Inc. (2012) Uganda Demographic and Health Survey 2011. UBOS and Calverton, Kampala. ICF International Inc., Maryland.
[9] Hussain, R. (2013) Unintended Pregnancy and Abortion in Uganda, in Brief. Guttmacher Institute, New York.
[10] Khan, S., Bradley, E.K.S., Joy, F. and Mishra, V. (2008) Unmet Need and the Demand for Family Planning in Uganda. Further Analysis of the Uganda Demographic and Health Surveys, 1995-2006 Calverton, Maryland, Macro International, MEASURE DHS, 42 p (USAID Contract No. GPO-C-00-03-00002-00; DHS Further Analysis No. 60). http://wwwpoplineorg/node/203998#sthash7KiKxy5Zdpuf
[11] Cameron, I.T. and Baird, D.T. (1988) The Return to Ovulation Following Early Abortion: A Comparison between Vacuum Aspiration and Prostaglandin. Acta Endocrinologica (Copenhagen), 118, 161-167.
[12] Lahteenmaki, P. and Luukkainen, T. (1978) Return of Ovarian Function after Abortion. Clinical Endocrinology, 8, 123-132.
[13] Grimes, D.A., Gallo, M.F., Grigorieva, V., Nanda, K. and Schulz, K.F. (2004) Fertility Awareness-Based Methods for Contraception. The Cochrane Database of Systematic Reviews.
[14] Goodman, S., Hendlish, S.K., Reeves, M.F. and Foster-Rosales, A. (2008) Impact of Immediate Postabortal Insertion of Intrauterine Contraception on Repeat Abortion. Contraception, 78, 143-148.
[15] Goodman, S., Hendlish, S.K., Benedict, C., Reeves, M.F., Pera-Floyd, M. and Foster-Rosales, A. (2008) Increasing Intrauterine Contraception Use by Reducing Barriers to Post-Abortal and Interval Insertion. Contraception, 78, 136-142.
[16] Shaw, D. (2010) The FIGO Initiative for the Prevention of Unsafe Abortion. International Journal of Gynaecology and Obstetrics, 110, S17-S19.
[17] Trussell, J. and Vaughan, B. (1999) Contraceptive Failure, Method-Related Discontinuation and Resumption of Use: Results from the 1995 National Survey of Family Growth. Family Planning Perspectives, 31, 64-72.
[18] Secura, G.M., Allsworth, J.E., Madden, T., Mullersman, J.L. and Peipert, J.F. (2010) The Contraceptive CHOICE Project: Reducing Barriers to Long-Acting Reversible Contraception. American Journal of Obstetrics and Gynecology, 203, 115.e1-115.e7.
[19] Rosenberg, M.J., Waugh, M.S. and Long, S. (1995) Unintended Pregnancies and Use, Misuse and Discontinuation of Oral Contraceptives. The Journal of Reproductive Medicine, 40, 355-360.
[20] Trussell, J., Lalla, A.M., Doan, Q.V., Reyes, E., Pinto, L. and Gricar, J. (2009) Cost Effectiveness of Contraceptives in the United States. Contraception, 79, 5-14.
[21] d’Arcangues, C. (2007) Worldwide Use of Intrauterine Devices for Contraception. Contraception, 75, S2-S7.
[22] Speidel, J.J., Harper, C.C. and Shields, W.C. (2008) The Potential of Long-Acting Reversible Contraception to Decrease Unintended Pregnancy. Contraception, 78, 197-200.
[23] Bulatao, R.A. and Lee, R.D., Eds. (1983) Determinants of Fertility in Developing Countries. Academic Press, New York.
[24] Castro Martin, T. and Juarez, F. (1994) Women’s Education and Fertility in Latin America: Exploring the Significance of Education for Women’s Lives. Demographic and Health Surveys Working Papers No. 10, Macro International, Calverton.
[25] NVivo Qualitative Data Analysis Software. Version 10, QSR International Pty Ltd., 2012.
[26] Morse, J.E., Rowen, T.S., Steinauer, J., Byamugisha, J. and Kakaire, O. (2014) A Qualitative Assessment of Ugandan Women’s Perceptions and Knowledge of Contraception. International Journal of Gynaecology and Obstetrics, 124, 30-33.
[27] Williamson, L.M., Parkes, A., Wight, D., Petticrew, M. and Hart, G.J. (2009) Limits to Modern Contraceptive Use among Young Women in Developing Countries: A Systematic Review of Qualitative Research. Reproductive Health, 6, 3.
[28] Gebremariam, A. and Addissie, A. (2014) Intention to Use Long Acting and Permanent Contraceptive Methods and Factors Affecting It among Married Women in Adigrat Town, Tigray, Northern Ethiopia. Reproductive Health, 11, 24.
[29] Saeed, G.A., Fakhar, S., Rahim, F. and Tabassum, S. (2008) Change in Trend of Contraceptive Uptake—Effect of Educational Leaflets and Counseling. Contraception, 77, 377-381.
[30] Weston, M.R., Martins, S.L., Neustadt, A.B. and Gilliam, M.L. (2012) Factors Influencing Uptake of Intrauterine Devices among Postpartum Adolescents: A Qualitative Study. American Journal of Obstetrics and Gynecology, 206, 40.e1-40.e7.
[31] Mohamed, A.M., Rachael, S.K., Cleland, J.N., Thoai, D. and Shah, I.H. (2011) Long-Term Contraceptive Protection, Discontinuation and Switching Behavior: Intrauterine Device (IUD) Use Dynamics in 14 Developing Countries. World Health Organization and Marie Stopes International, London.
[32] Bahamondes, L., Del Castillo, S., Tabares, G., Arce, X.E., Perrotti, M. and Petta, C. (2001) Comparison of Weight Increase in Users of Depot Medroxyprogesterone Acetate and Copper IUD up to 5 Years. Contraception, 64, 223-225.
[33] Hassan, D.F., Petta, C.A., Aldrighi, J.M., Bahamondes, L. and Perrotti, M. (2003) Weight Variation in a Cohort of Women Using Copper IUD for Contraception. Contraception, 68, 27-30.
[34] Bulto, G.A., Zewdie, T.A. and Beyen, T.K. (2014) Demand for Long Acting and Permanent Contraceptive Methods and Associated Factors among Married Women of Reproductive Age Group in Debre Markos Town, North West Ethiopia. BMC Women’s Health, 14, 46.
[35] Takele, A., Degu, G. and Yitayal, M. (2012) Demand for Long Acting and Permanent Methods of Contraceptives and Factors for Non-Use among Married Women of Goba Town, Bale Zone, South East Ethiopia. Reproductive Health, 9, 26.
[36] Chipeta, E.K., Chimwaza, W. and Kalilani-Phiri, L. (2010) Contraceptive Knowledge, Beliefs and Attitudes in Rural Malawi: Misinformation, Misbeliefs and Misperceptions. Malawi Medical Journal: The Journal of Medical Association of Malawi, 22, 38-41.
[37] Kabagenyi, A., Jennings, L., Reid, A., Nalwadda, G., Ntozi, J. and Atuyambe, L. (2014) Barriers to Male Involvement in Contraceptive Uptake and Reproductive Health Services: A Qualitative Study of Men and Women’s Perceptions in Two Rural Districts in Uganda. Reproductive Health, 11, 21.
[38] Chacko, E. (2001) Women’s Use of Contraception in Rural India: A Village-Level Study. Health & Place, 7, 197-208.
[39] Stephenson, R., Baschieri, A., Clements, S., Hennink, M. and Madise, N. (2007) Contextual Influences on Modern Contraceptive Use in Sub-Saharan Africa. American Journal of Public Health, 97, 1233-1240.
[40] Neukom, J., Chilambwe, J., Mkandawire, J., Mbewe, R.K. and Hubacher, D. (2011) Dedicated Providers of Long-Acting Reversible Contraception: New Approach in Zambia. Contraception, 83, 447-452.
[41] Glasier, A. (2002) Implantable Contraceptives for Women: Effectiveness, Discontinuation Rates, Return of Fertility, and Outcome of Pregnancies. Contraception, 65, 29-37.
[42] Andersson, K., Batar, I. and Rybo, G. (1992) Return to Fertility after Removal of a Levonorgestrel-Releasing Intrauterine Device and Nova-T. Contraception, 46, 575-584.
[43] Morse, J., Freedman, L. and Speidel, J.J., Thompson, K.M., Stratton, L. and Harper, C.C. (2012) Postabortion Contraception: Qualitative Interviews on Counseling and Provision of Long-Acting Reversible Contraceptive Methods. Perspectives on Sexual and Reproductive Health, 44, 100-106.
[44] Moreno, V., Bosch, F.X., Munoz, N., Meijer, C.J., Shah, K.V., Walboomers, J.M., Herrero, R. and Franceschi, S. (2002) Effect of Oral Contraceptives on Risk of Cervical Cancer in Women with Human Papillomavirus Infection: The IARC Multicentric Case-Control Study. The Lancet, 359, 1085-1092.
[45] Appleby, P., Beral, V., de González, A.B., Colin, D., Franceschi, S., Goodhill, A., Green, J., Peto, J., Plummer, M. and Sweetland, S. (2007) Cervical Cancer and Hormonal Contraceptives: Collaborative Reanalysis of Individual Data for 16,573 Women with Cervical Cancer and 35,509 Women without Cervical Cancer from 24 Epidemiological Studies. The Lancet, 370, 1609-1621.
[46] Benshushan, A., Paltiel, O., Rojanskya, N., Brzezinskia, A. and Laufer, N. (2002) IUD Use and the Risk of Endometrial Cancer. European Journal of Obstetrics & Gynecology and Reproductive Biology, 105, 166-169.
[47] Castellsague, X., Diaz, M., Vaccarella, S., de Sanjose, S., Munoz, N., Herrero, R., Franceschi, S., Meijer, C.J. and Bosch, F.X. (2011) Intrauterine Device Use, Cervical Infection with Human Papillomavirus, and Risk of Cervical Cancer: A Pooled Analysis of 26 Epidemiological Studies. The Lancet Oncology, 12, 1023-1031.
[48] Chiou, C.F., Trussell, J., Reyes, E., Knight, K., Wallace, J., Udani, J., Oda, K. and Borenstein, J. (2003) Economic Analysis of Contraceptives for Women. Contraception, 68, 3-10.
[49] Wickstrom, J. and Jacobstein, R. (2011) Contraceptive Security: Incomplete without Long-Acting and Permanent Methods of Family Planning. Studies in Family Planning, 42, 291-298.

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.